NCT00052130 2005-06-24Vaccine Therapy for Patients With Stage III MelanomaCancerVax CorporationPhase 3 Unknown1,118 enrolled
NCT00052156 2005-06-24Vaccine Therapy for Patients With Stage IV MelanomaCancerVax CorporationPhase 3 Unknown670 enrolled